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Review
THE LONG-TERM EFFICACY OF ACUTE-PHASE
PSYCHOTHERAPY FOR DEPRESSION: A META-ANALYSIS
OF RANDOMIZED TRIALS
Eirini Karyotaki, M.Sc. Res.,1,2∗ Yolba Smit, M.D.,3 Derek P. de Beurs, Ph.D., M.Sc.,1,2
Kirsten Holdt Henningsen, M.H.A.,4 Jo Robays, Ph.D.,5 Marcus J. H. Huibers, Ph.D.,1,2 Erica Weitz, M.A.,1,2
and Pim Cuijpers, Ph.D.1,2
Background: Understanding the effectiveness of treatment for depression in
both the short term and long term is essential for clinical decision making. The
present meta-analysis examined treatment effects on depression and quality of
life in acute-phase psychotherapeutic interventions compared to no treatment
control groups for adult depression at 6 months or longer postrandomization.
Methods: A systematic literature search resulted in 44 randomized controlled
trials with 6,096 participants. Acute-phase psychotherapy was compared to con-
trol groups at 6-month or longer postrandomization. Odds ratios of a positive
outcome were calculated. Results: Psychotherapy outperformed control groups
at 6 months or longer postrandomization (OR = 1.92, 95% CI: 1.60–2.31, P <
.001). Heterogeneity was moderate (I²: 65, 95% CI: 53–74, P < .001). However,
effects significantly decreased with longer follow-up periods. Additionally, a small
positive effect of psychotherapy was observed for quality of life, while similar ef-
fects were obtained in separate analyses of each type of psychotherapy, with the
exception of nondirective supportive therapy. Studies that provided booster ses-
sions had better treatment results compared with studies that did not provide any
further sessions. Finally, we found that trials on psychotherapy aimed at major
depressive disorder (MDD) had better outcomes than those that were aimed at
elevated depressive symptoms. Conclusions: There is substantial evidence that
acute-phase psychotherapy results in a better treatment effects on depression and
quality of life in the long term for adult patients with depression. Depression and
Anxiety 33:370–383, 2016. C© 2016 Wiley Periodicals, Inc.
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INTRODUCTION
Depression, a highly prevalent and disabling disorder,
constitutes a major public health issue worldwide. Epi-
demiological studies have shown that 14.6% of individ-
uals in developed countries have experienced a major
∗Correspondence to: Eirini Karyotaki, Department of Clinical Psy-
chology, VU University Amsterdam, Van der Boechorststraat 1,
1081 BT Amsterdam, the Netherlands. E-mail: e.karyotaki@vu.nl
Received for publication 21 September 2015; Revised 13 January
2016; Accepted 19 February 2016
DOI 10.1002/da.22491
Published online 21 March 2016 in Wiley Online Library
(wileyonlinelibrary.com).
C© 2016 Wiley Periodicals, Inc.
Review: The Long-Term Efficacy of Acute-Phase Psychotherapy for Depression 371
depressive episode at some point throughout lifetime.[1]
In addition to high prevalence rates, depression is cur-
rently ranked first among mental disorders with re-
gard to disease burden, according to the World Health
Organization.[2] This disease burden results from the
large impact of depressive disorder on individuals’ lives,
as depression adversely affects quality of life. Depres-
sive disorder is also associated with increased mortal-
ity rates and high economic and societal cost.[3–5] Ad-
ditionally, depression has high relapse rates, which in
turn increase the chance of depression developing into
a chronic condition.[6, 7] Keller[8] estimated that individ-
uals who have experienced one episode of depression
have 50% chance of experiencing a second episode, while
those who have experienced a second episode have 90%
chance of experiencing a third.[8]
The high adverse impact of depression on individuals’
lives underscores the need for treatment. Maintenance
pharmacotherapy is currently the most widely used
treatment in preventing relapse of depressive episodes.
Antidepressant medication reduces the risk of relapse,
especially when used for long periods of time.[9] How-
ever, a notable number of patients have a preference
for short-term use of antidepressants resulting in low
adherence to medication and leading to recidivism.
Moreover, research has shown that a considerable
percentage of individuals with depression prefer psy-
chotherapy to pharmacotherapy.[10] Psychotherapy aims
at helping individuals to develop adaptive mechanisms
in order to be more functional in their lives and to
effectively cope with depression. Psychotherapy intends
to alleviate symptoms of an active depression but also
works to prevent future relapses and maintain the
favourable treatment response over a lengthy time.
It is well known that acute-phase psychotherapy (psy-
chotherapy targeted at an active depression) is effective
in the treatment of depressive disorders in short term.
For instance, a recent meta-analysis carried out by Cui-
jpers et al.[11] examined the effects of cognitive behav-
ioral therapy (CBT) in treating adult depression. The
authors found a large effect size in favour of CBT com-
pared to control groups (d = 0.71) at the posttreatment
assessment.[11] Similar results have been presented for
several other major types of psychotherapy, such as inter-
personal psychotherapy[12] and behavioral activation.[13]
Despite these favourable short-term effects, there is lit-
tle rigorous meta-analytic evidence regarding long-term
outcomes of psychotherapy on depression.
Given the high risk of relapse, it is critical to examine
whether psychotherapy results in an enduring effect on
depression. Poor long-term outcomes lead to increased
health care service utilization and consequently to higher
costs for the public healthcare system.[14] Results derived
from a meta-analysis by Piet et al.[15] showed that main-
tenance mindfulness-based cognitive therapy (MBCT)
resulted in a better reduction of depressive symptoms
in comparison with treatment as usual or pill placebo at
6 months follow-up. This corresponds to a relative risk
reduction of 34% in favour of MBCT.[15] These results
are in accordance with the meta-analysis of Biesheuvel-
Leliefeld et al.[16] The authors examined the effectiveness
of maintenance psychotherapy compared to treatment as
usual (TAU) in reducing relapse or recurrence in patients
with major depressive disorder (MDD). The results indi-
cated that maintenance psychotherapeutic interventions
reduced significantly the risk of relapse (RR = 0.64) in
patients with MDD.[16]
To the best of our knowledge there is no systematic
review that has examined the long-term effects of acute-
phase psychotherapy compared to control groups. Such
a systematic review would extend our knowledge from
short-term to long-term outcomes and would assist us
in guiding clinical decisions and planning processes re-
garding depression treatment strategies in primary and
secondary mental health care. Moreover, it would give
an indication of the number of patients that maintain
treatment response in the long term, after receiving
acute-phase psychotherapy. The aim of the present
meta-analysis is to examine long-term treatment effects
on depression and quality of life at 6 months or longer
postrandomization to either acute-phase psychotherapy
for depression or a control group. The hypothesis is
that psychotherapeutic interventions will outperform
the control groups on depression and quality of life at
6 months or longer postrandomization.
METHODS
DEFINITIONS
Psychotherapy was defined as an intervention in which either ver-
bal communication between a therapist and a client is the core el-
ement, or in which a psychological treatment is contained in book
(bibliotherapy) or electronic format (Internet-based treatment), which
a patient works through more or less independently, but with some
personal support from a therapist (guided by telephone, e-mail, or
otherwise).[17] In the present meta-analysis, we used a definition of
psychotherapy based on taxonomy of psychotherapy types for depres-
sion developed by a group of experts in the field.[17] The classification
was based on a systematic search for studies on psychological treat-
ments for depression, using broad definitions for psychotherapy. This
process resulted in seven major types of psychotherapy for depression:
behavioral activation (BA), cognitive behavioral therapy (CBT), inter-
personal psychotherapy (IPT), nondirective supportive therapy (SUP),
psychodynamic psychotherapy (DYN), and social skills training (SST)
(see Appendix A).
Acute-phase psychotherapy was defined as the short-term psy-
chotherapy delivered during the occurrence of depressive symptoms,
as opposed to maintenance psychotherapy that can be delivered during
remission/recovery of depressive symptoms.
INCLUSION CRITERIA
We selected randomized controlled trials (RCTs) including adult
patients with depression (based on a clinical interview or on elevated
depressive symptoms ratings on symptom scales). The selected inter-
ventions were all main psychotherapeutic interventions (as described
above), while the selected comparison groups were usual care, waiting
list, no treatment (no pharmacotherapy), or pill placebo. Light ther-
apy or other types of psychotherapy, not defined as a main type of
psychotherapy according to the definition described above, were not
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considered eligible as a comparison. We only included studies pub-
lished and written in English.
SEARCH STRATEGY
We searched Medline (PubMed.com), PsycINFO (Ebsco), Embase
(embase.com), and the Cochrane library (cochranelibrary.com) from
database inception to January 1, 2015. We used index and text words
indicating psychotherapy combined with key terms for depression. We
used a filter for RCTs as recommended in the Cochrane Handbook.[18]
The full search string for PubMed is given in Appendix B. Addition-
ally, we searched an existing database on psychological treatments for
depression in order to increase the probability of identifying eligible
citations. This database has been developed and updated through lit-
erature searches in PubMed, PsycINFO, Embase, and the Cochrane
Central Register of Control trials from January 2006 until January
2015.[19] Furthermore, references of selected studies were searched to
identify additional relevant studies. Two reviewers (E.K. and Y.S. or
D.B. or E.W.) independently examined abstracts for eligibility. Stud-
ies that met inclusion criteria were examined in full text. In the case of
disagreement, the opinion of a third reviewer (P.C.) was sought.
DATA EXTRACTION
The following data were extracted: reference, years of inclusion,
country, patient characteristics (e.g. target group: adults in general,
specific target group, such as older adults, women with postpartum de-
pression, etc.), therapy characteristics (type of psychotherapy, number
of treatment sessions etc.), control characteristics (e.g. type of control),
and type and length of follow-up period. Most studies in this field used a
naturalistic follow-up. Therefore, for each study we reported how long
the follow-up period lasted, but also whether there was regular con-
tact with a therapist. In some studies, outcome data were only reported
for patients who responded to treatment in the acute-phase treatment
phase, while others reported outcomes for the full intention-to-treat
sample. Two reviewers (E.K. and D.B.) extracted data independently;
a third reviewer (P.C.) checked the data extraction.
QUALITY ASSESSMENT
The quality of the included RCTs was examined by two reviewers
(E.K. and Y.S. or D.B.) independently, according to Cochrane Risk
of Bias tool.[20] Any disagreement between the reviewers was solved
through discussion.
STATISTICAL ANALYSIS
We focused on all positive dichotomous outcomes on depression.
In the context of the present paper, this combination of all positive
outcomes is defined as “all positive outcomes combined.” For the ex-
amined comparison between psychotherapy and control conditions we
calculated the odds ratio (OR) of all positive outcomes combined based
on dichotomous results. The following outcomes were extracted from
the studies and were entered into the analysis hierarchically (when
the first outcome in the hierarchy was not available the next available
outcome was used):
1. Recovery (absence of depressive symptoms for 4 months after
remission)
2. Remission (no depressive symptoms; BDI I and II < 11; HAMD-17
and 21 < 8; MADRS < 7; PHQ-9 < 5)
3. Partial remission (no depressive symptoms or mild depressive
symptoms; BDI I and II < 14; HAMD-17 and 21 < 14; MADRS <
20; PHQ-9 < 10)
4. Response (50% reduction from baseline severity on any depression
measure)
5. If no dichotomous outcomes were reported, we calculated the stan-
dardized mean difference (SMD) as the difference in mean scores
divided by the pooled standard deviation. Subsequently, the mean
difference was transformed into the OR according to the procedures
given by Borenstein et al.[21]
For dichotomous outcomes all randomized patients were taken as
the denominator and reported outcomes in completers were taken
as the numerator, thus simulating a last observation carried forward
procedure. We also conducted meta-analyses for recovery, remission,
partial remission, and response rates separately.
Regarding the outcome quality of life, we calculated the effect sizes
(Hedges’s g) for the global quality of life (social functioning, physical,
and mental health). Hedge’s g allows for small sample bias correction
and is calculated by subtracting the average score (on global quality of
life) of the psychotherapy group from the average score of the control
group (at the follow-up) and dividing the results by the pooled standard
deviation.[22]
We calculated pooled odds ratios using the Comprehensive Meta-
Analysis (version 2.2.021) program. We expected considerable hetero-
geneity among the studies, so we used a random effects model to pool
the results of the included RCTs.
The statistical heterogeneity was examined for all the outcomes
of the present meta-analysis. This type of heterogeneity refers to the
variability of the intervention effects between the included studies and
indicates how much of the variability between studies can be explained
by chance alone. Statistical heterogeneity can be caused by variability
among the participants, interventions, outcomes, and design of the
included studies.[23] The I2-statistic, an indicator of heterogeneity in
percentages, was calculated in order to examine the homogeneity of
the effect sizes. Heterogeneity was not observed if the resulted value of
I2 = 0%, as low when I2 = 1–25%, as moderate when I2 = 26–74% and
as high when I2  75%. We calculated 95% confidence intervals (CI)
around I2[[24]] using the noncentral chi-squared based approach within
the heterogi module for Stata.[25] The Q-statistic was calculated, and
reported when significant.
We examined publication bias by examining the funnel plot on
primary outcome measures and by using the Duval and Tweedie’s
trim and fill procedure.[26,27] This procedure provides an estimate of
the effect size after adjusting for publication bias (as implemented in
Comprehensive Meta-analysis, version 2.2.021). Finally, we used Eg-
ger’s test of the intercept to test the asymmetry of the funnel plot and
examine whether this possibility of publication bias was significant.[28]
RESULTS
STUDY SELECTION
The systematic literature search was performed on
January 1, 2015. This search resulted in 15,057 citations.
After removal of duplicates, 9,204 single citations were
examined on title and abstract. This procedure led to
1,471 articles that were reviewed full text. Forty-four
studies met the inclusion criteria and were included in
the meta-analyses. Figure 1 presents the study selection
process.
STUDY CHARACTERISTICS
Table 1 presents the characteristics of the included
studies. Forty-four studies and five companion papers
with a total number of 6,096 participants with depres-
sion evaluated the effects of psychotherapy compared to
control groups at 6 months or longer postrandomization.
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Figure 1. Flow chart of studies selection process.
Most of the included studies recruited their participants
through clinical settings (n = 33) while nine studies re-
cruited their participants through community samples
and two studies used both clinical and community re-
ferrals. The included RCTs were conducted across 12
different countries: Australia, Brazil, China, Finland, Ire-
land, Norway, Spain, the Netherlands, the United King-
dom, the United States, Turkey, and Uganda. All stud-
ies used all of the initially randomized participants at
the follow-up assessment. The follow-up duration var-
ied from 6 to 18 months postrandomization. Most of the
included studies did not report on the issue of out-of-
protocol interval treatment during follow-up. Only four
trials reported that participants were free to access treat-
ment after the acute-phase therapy (naturalistic follow-
up; Appendix C).
Among the examined types of psychotherapy were
behavioral activation, cognitive behavioral therapy,
interpersonal psychotherapy, nondirective supportive
therapy, problem solving therapy, and psychodynamic
therapy. We found no trials on long-term effects of so-
cial skills training. In the majority of the included stud-
ies, psychotherapy was administered face to face while six
studies used web-based or telephone-based psychother-
apy. The number of treatment sessions varied from four
to 26 usually weekly sessions (more details on the du-
ration of the therapy can be found in Appendix C).
Most of the included studies used TAU as the control
comparison condition. The definition of TAU varied
across different studies and countries. In the included
trials, TAU was mostly defined as therapy carried out by
general practitioners (GPs), referrals to community
mental health services and/or nonspecific antidepres-
sant medications. Other types of control conditions
were attention controls, life style interventions, no fur-
ther assessment, nonspecific antidepressant medication,
placebo alone or with clinical management, no treatment
and waiting list (further details regarding the control
conditions can be found in Appendix C).
RISK OF BIAS OF THE INCLUDED STUDIES
The quality of the included studies varied. Most of
the studies presented adequate random sequence gener-
ation (31/44) while the allocation was adequate in 16 of
the included RCTs. In the vast majority of the studies
blinding of participants was not possible due to the na-
ture of the psychotherapeutic interventions. However,
one RCT used placebo psychotherapy. Finally, 26 stud-
ies used intention-to-treat analyses to handle incomplete
outcome data and most of the studies were evaluated at
a low risk for selective reporting (42/44) while all studies
were free from other sources of bias (Fig. 2).
ACUTE PSYCHOTHERAPY VERSUS CONTROL
CONDITIONS (AT 6 MONTHS
POSTRANDOMIZATION)
All Positive Outcomes Combined and Quality of
Life. The results of all the meta-analyses are presented
in Table 2. Forty-four studies (55 comparisons) com-
pared psychotherapy to control groups at 6 months or
longer postrandomization. Psychotherapy significantly
Depression and Anxiety
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Figure 2. Risk of bias assessment.
outperformed control groups (OR = 1.92, P < .001).
Heterogeneity was moderate (I²: 65%, P < .001). The
ORs and 95% CIs are presented in Fig. 3. Visual in-
spection of Fig. 3 suggested that two studies[29, 30] were
outliers because the 95% CIs around their effect sizes did
not overlap with the 95% CIs around the overall pooled
effect size. Thus, we decided to exclude these two studies
to examine the impact on heterogeneity. The resulting
effect remained significant in favour of psychotherapy
(OR = 1.65, P < .001), while the heterogeneity was re-
duced considerably to I² = 20% (P > .05). Due to this
important reduction in heterogeneity, we decided to ex-
clude these two studies from all further analyses. How-
ever, after the removal of the outliers, there was an indi-
cation for publication bias (see funnel plot 1 in Appendix
D). In Duval and Tweedie’s Trim and fill procedure the
imputed point estimate changed to OR = 1.45 (95% CI:
1.27–1.67) after adjustment for publication bias, while
Egger’s test was significant (P < .05).
In seven included studies, acute-phase psychotherapy
was followed by booster sessions. These sessions were
provided in the event that some patients needed further
treatment. Considering that this type of continuation
psychotherapy might have influenced the maintenance
outcomes of psychotherapy, we decided to exclude these
trials in a sensitivity analysis. The results of this anal-
ysis (44 comparisons) indicated that psychotherapy sig-
nificantly outperformed control groups at 6 months or
longer postrandomization (OR = 1.58, P < .05). How-
ever, Duval and Tweedie’s Trim and fill procedure re-
sulted in an adjusted OR of 1.39 (95% CI: 1.19–1.62)
and Egger’s test was significant (P < .05) (see also funnel
plot 2 in Appendix D).
In order to examine possible sources of heterogeneity,
we conducted a series of subgroup analyses (Table 2).
We found significant differences between subgroup of
studies that were specifically targeted at individuals with
MDD (diagnosed by a clinical interview) and stud-
ies that recruited individuals who scored high on self-
report outcome measures (P < .05). Subgroup anal-
ysis also revealed a significant difference between the
studies that provided booster sessions after the comple-
tion of therapy, and studies that provided no additional
sessions (P < .05). Other subgroup analyses did not result
in significant differences. Moreover, we conducted meta-
regression analyses to examine the associations between
the dependent variable “all positive outcomes combined”
and the independent variables “number of sessions” and
“follow-up duration.” Results indicated that the effect
of psychotherapy significantly decreased as the follow-
up duration increased (slope: −0.07, 95% CI: −0.10 to
−0.04, P < .001; Fig. 4). No significant association was
found between response to treatment and number of ses-
sions (slope: 0.001, 95% CI: −0.02 to 0.03, P > .05).
With regard to quality of life, psychotherapy resulted
in a significantly better quality of life compared to con-
trol groups at  6 months postrandomization across the
eight studies that examined this outcome (Hedges’s g =
0.22, 95% CI: 0.11–0.32, P < .001; Fig. 5). Heterogene-
ity was zero (95% CI: 0–68%, P < .001).
Recovery, Remission, Partial Remission, and Re-
sponse. Separate meta-analyses were conducted for
recovery, remission, partial remission, and response rates
at 6 months or longer postrandomization. Recovery was
reported in five comparisons between psychotherapy
and control groups. Psychotherapy outperformed con-
trol conditions (OR = 1.77, P < .05). Similar long-
term effects were observed for remission across ten
comparisons. Psychotherapy resulted in higher remis-
sion rates compared to control groups (OR = 1.70,
P < .05) Heterogeneity was moderate. Partial remission
was examined across nine comparisons. Psychotherapy
outperformed control groups on partial remission rates
(OR = 1.61, P < .05). Heterogeneity was low. There
was a small indication for publication bias (see funnel
plot 3 in Appendix D). Using the trim and fill procedure,
the imputed OR was 1.51 (P < .05), however, Egger’s
test was not significant. Finally, response rates were ex-
amined across five comparisons. Psychotherapy resulted
in significantly higher response rates compared to con-
trols (OR = 2.06, P < .001) and the heterogeneity was
low.
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TABLE 2. Long-term effects of psychotherapy in adults with depression compared to control groups (at  6 months
postrandomization)
All types of psychotherapy vs. controls N OR 95% CI I ² 95% CI P
All positive outcomes combined 55 1.92 1.60–2.31 65 53–74 .000
All positive outcomes combined (two outliers excluded) 53 1.65 1.46–1.87 20 0–43 .000
All positive outcomes combined (psychotherapy with booster sessions excluded) 44 1.58 1.38–1.81 22 0–66 .000
Recovery 5 1.74 1.09–2.75 30 0–73 .025
Remission 10 1.70 1.20–2.45 57 14–79 .003
Partial remission 9 1.61 1.16–2.22 3 0–66 .004
Response 7 2.06 1.53–2.80 19 0–63 .000
CBT vs. controls
All positive outcomes combined 36 1.70 1.45–1.98 18 0–46 .000
IPT vs. controls
All positive outcomes combined 6 1.90 1.30–2.77 0 0–75 .001
SUP vs. controls
All positive outcomes combined 5 1.39 0.86–2.24 52 0–83 .181
PST vs. controls
All positive outcomes combined 3 1.91 1.16–3.15 34 0–78 .011
Subgroups—all positive outcomes combined
CBT CBT vs. 36 1.70 1.45–1.98 18 0–46 .60
other PT 17 1.58 1.29–1.96 25 0–58
IPT IPT vs. 6 1.90 1.30–2.77 0 0–75 .46
other PT 47 1.63 1.43–1.86 23 0–47
SUP SUP vs. 6 1.90 1.30–2.77 0 0–75 .44
other PT 48 1.69 1.48–1.91 14 0–40
PST PST vs. 3 1.91 1.16–3.15 34 0–78 .56
other PT 50 1.64 1.44–1.87 20 0–44
Control group TAU vs. 37 1.65 1.43–1.90 16 0–44 .84
other 16 1.70 1.32–2.18 31 0–62
Diagnosis MDD vs. 25 1.88 1.53–2.31 26 0–55 .04
other 28 1.45 1.27–1.66 0 0–42
Quality of studies High (defined as low scores
in 4 items) vs.
32 1.56 1.33–1.82 31 0–56 .15
low quality studies 21 1.88 1.53–2.32 0 0–47
Recruitment Community vs. 17 1.40 1.11–1.75 28 0–60 .07
clinical sample 36 1.78 1.56–2.03 3 0–40
Target group Older adults vs. 7 1.99 1.42–2.78 0 0–71 .51
postpartum vs. 8 1.53 0.96–2.43 41 0–74
other 38 1.63 1.42–1.87 21 0–47
Therapy continuation Booster sessions vs. 9 2.21 1.67–2.91 0 0–65 .03
no further continuation of
the therapy
44 1.58 1.38–1.81 22 0–46
Treatment format Individual vs. 44 1.63 1.43–1.87 25 0–49 .46
group format 9 1.88 1.32–2.67 0 0–46
Type of therapy BA vs. 1 1.8 0.96–3.45 NA NA .73
CBT vs. 36 1.70 1.45–1.98 18 0–46
DYN vs. 2 1.10 0.56–2.16 36 NA
IPT vs. 6 1.90 1.30–2.77 0 0–75
PST vs. 3 1.91 1.16–3.15 34 0–78
SUP 6 1.90 1.30–2.77 0 0–75
BA, behavioral activation; CBT, cognitive behavioral therapy; CI, confidence intervals; DYN, psychodynamic psychotherapy; IPT, interpersonal
psychotherapy; IPT, interpersonal psychotherapy; MDD, major depressive disorder; N, number of comparisons; OR, odds ratio; PST, problem
solving therapy; PT, psychotherapy; SUP, nondirective supportive therapy; TAU, treatment as usual.
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Figure 3. Forest plot of all positive outcomes combined.
Long-Term Effects of Individual Psychothera-
pies. We conducted separate meta-analyses for each
type of psychotherapy when three or more studies were
available. If less than three studies were available, results
were described narratively. The outcomes of the individ-
ual comparisons are presented in Table 2. CBT resulted
in a significantly higher positive therapy outcomes com-
pared to control groups across 36 comparisons (OR =
1.70, P < .001). Heterogeneity was low. However, using
Duval and Tweedie’s Trim and fill procedure the values
changed to OR = 1.51 (95% CI 1.27–1.79), while Eg-
ger’s test was significant (P < .05) (see also funnel plot
4 in Appendix D). IPT outperformed control groups on
all positive outcomes combined (OR = 1.90, P < .05)
across six comparisons. Heterogeneity was zero. SUP
did not result in significant long-term differences com-
pared to control conditions in all positive outcomes com-
bined (five comparisons). PST resulted in higher positive
outcomes rates compared to controls at 6 months or
longer postrandomization (OR = 1.91, P < .05) across
three comparisons. Only one study was found on long-
term effects of DYN therapy. Simpson et al. reported
that DYN therapy significantly outperformed control
groups in partial remission rates at 6 months follow up.
Finally, we found one study examining the long-term
effects of BA. Pagoto et al. found that BA resulted in
higher remission and response rates compared to light
intervention group at 6 months follow up.
DISCUSSION
To the best of our knowledge this is the first systematic
review examining the long-term effects of acute-phase
psychotherapy compared to control groups in adults with
depression. Our hypothesis that psychotherapy would
outperform the control groups on all-positive outcomes
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Figure 4. Meta-regression analysis of the association between follow-up duration and treatment outcome.
combined (recovery, remission, partial remission, re-
sponse, and reduction in depression severity) and on
quality of life was confirmed at a follow-up of 6 months
or longer. This conclusion was replicated by analyzing
each type of dichotomous outcome separately. Addi-
tionally, we examined the effects of different types of
psychotherapy individually and the results showed that
treatment gains were maintained through 6 months or
longer postrandomization across all types of psychother-
apy with the exception of nondirective supportive treat-
ment, which was found to be less efficacious. We also
found that in the long-term, psychotherapy resulted in
higher effects compared to control groups when it was
provided with additional booster sessions, or when it
was exclusively targeted at adults with MDD. Finally,
the results of this systematic review indicated that as
the follow-up progressively increased the effects of psy-
chotherapy versus control decreased.
Our findings are in line with previous work of Piet
and Hougaard[15] and Biesheuvel-Leliefeld et al.[16] Piet
and Hougaard[15] found a relative risk reduction of 34%
in favour of maintenance mindfulness-based cognitive
therapy compared to treatment as usual or pill placebo at
6 months or longer postrandomization in patients with
MDD. Moreover, Biesheuvel-Leliefeld et al.[16] found
that maintenance psychotherapy reduced significantly
the risk of relapse in patients with MDD. To our knowl-
edge there is no other systematic review on the long-
term effects of acute-phase psychotherapy. Moreover,
the finding that different types of psychotherapy, with
the exception of nondirective supportive therapy, re-
sult in similar effects in treating depression is consistent
with the meta-analyses of direct comparisons of different
types of psychotherapy conducted by Cuijpers et al.[17]
and Barth et al.[79] These meta-analyses showed no sig-
nificant difference between the effects of seven major
types of psychotherapy in treating depression and that
nondirective supportive therapy is less efficacious com-
pared to other types of psychotherapy. It should be noted
at this point that although we analyzed and described
different types of psychotherapy separately, the inter-
pretation of the findings has to be done with caution as
Figure 5. Forest plot of quality of life.
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the majority of the included RCTs used CBT as a psy-
chotherapy intervention.
We observed a decreasing difference between psy-
chotherapy and control conditions over length of follow-
up. The reasons for this reduction vary among the exam-
ined trials. In certain instances, this decrease in effects is
due to greater relapse rates in the psychotherapy groups
as the effects of acute treatment waned. However, in the
majority of instances, this decrease in effects in the course
of time can be attributed to spontaneous remission rates
experienced by patients in the control groups. This is
in line with research findings suggesting that approxi-
mately half of the untreated patients who are diagnosed
with major depression will experience spontaneous re-
mission within a year.[80]
The finding that studies required a diagnosis of major
depression presented larger psychotherapy long-term
differences compared to studies that used elevated de-
pressive symptoms as inclusion criterion, is consistent
with previous research findings regarding the moderat-
ing effects of depression severity in treatment outcome.
The meta-analysis of Driessen et al. showed that psy-
chotherapy might be more efficacious for more severely
depressed individuals.[81] Furthermore, Bower et al.[82]
conducted an individual patient data meta-analysis to
examine the influence of baseline depression severity on
the effects of low intensity psychotherapeutic interven-
tion in outpatients with depression. The authors found
that patients who had more severe depressive symptoms
at baseline showed greater treatment effects in compar-
ison with patients who had less severe symptoms of de-
pression at the intake.[82]
The present study addresses, for the first time, the
long-term effects of psychotherapy on quality of life.
However, a recent systematic review by Kolovos et al.
(under submission)[83] came to similar conclusions re-
garding the short-term effects of psychotherapy on qual-
ity of life. The authors meta-analyzed the effects of 44
RCTs on global quality of life, mental and physical
components and found that psychotherapy has a posi-
tive impact on the quality of life at the posttreatment
assessment.[83]
The present study has several limitations. First, treat-
ment as usual was the most common control group used
by the included studies. However, this condition had in
some cases unclear definitions and generally presented
important variations across countries. We also observed
moderate heterogeneity between studies as a result of
two outliers and thus, these studies were excluded in any
further analyses. This difference, between the two stud-
ies and the rest studies of our sample, may have been
caused by differences in populations or by differences in
the control conditions. The study by Bass et al.[29] was
conducted in Uganda and the study of Qiu et al.[30] was
conducted in China, while the great majority of the rest-
included studies were conducted in western countries.
Thus, cultural differences may account for the observed
differences between these two studies and the rest of
the studies in our sample. Further, we observed some
indications for publication bias in our main comparison
between psychotherapy and control groups. However,
the superior effects of psychotherapy remained signif-
icant after adjustment for publication bias. The lower
effect size estimate of low quality studies was not signif-
icantly different from high quality studies. Finally, the
external validity of the present meta-analysis might be
limited due to the design of the included studies. A com-
mon difficulty of the RCT design is the limited duration
of the provided treatment. For instance, the vast ma-
jority of the included trials did not provide booster ses-
sions after acute-phase treatment. In contrast, therapists
in clinical practice often provide continuation and main-
tenance therapy to recently improved patients. Thus the
literature under examination represents a special case of
a particular research design for psychotherapy.
Future research should examine ways to maintain the
positive effects of psychotherapy during a more exten-
sive follow-up period. Additionally, maintenance psy-
chotherapy could be employed in order to sustain treat-
ment response as the follow-up duration progressively
increases. Studies should address the efficacy of differ-
ent types of psychotherapy, in order to provide enough
power to analyze the effects of each type of interven-
tion separately. It is also important to address questions
regarding predictors and moderators to treatment out-
comes on long-term follow-up. This will provide us with
essential information on who may benefit the most from
psychotherapy over time. This need should drive new
meta-analytic approaches such as individual patient data
meta-analysis. Furthermore, more research is needed to
address long-term effects of psychotherapy compared to
pharmacotherapy, as well as the effects of combined psy-
chotherapy and pharmacotherapy treatment. This would
provide us with important information regarding the op-
timal therapeutic approach with respect to the long-term
outcome of adult depression treatment.
In conclusion, acute-phase psychological interven-
tions appear promising in treating depression in the long
term. The improvement in depressive outcomes, while
less apparent as the follow up duration increased, was
considerable. Given the chronicity and disability asso-
ciated with depression, these findings should be taken
into account in clinical and policy decision making. Cur-
rently, pharmacotherapy is the predominant treatment
for depression with more and more patients being pre-
scribed with antidepressant medications in mental health
care services worldwide. However, concerns have arisen
about the side effects of antidepressants and about the
durability of their effects after discontinuation. The re-
sults of the present meta-analysis recommend that psy-
chological interventions may offer a viable approach
to improve long-term outcomes of depression care. In
light of these therapeutic gains, psychotherapy should
be available in primary and secondary mental health
care. Patients with depression should be able to dis-
cuss psychological treatment options with their doctors
and decide based on their preferences. Alternative treat-
ment modalities, such as maintenance psychotherapy or
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the combination of psychotherapy and pharmacotherapy
should also be considered to sustain long-term benefits.
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